ArticleCrohn's & colitis 3602022

Probability of Response as Defined by a Clinical Decision Support Tool Is Associated With Lower Healthcare Resource Utilization in Vedolizumab-Treated Patients With Crohn's Disease.

Parambir S Dulai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.